Clinical trial
The Experimental Treatment of Transfusion Dependent 5q Minus Syndrome With Leucovorin
NCT00004997 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Experimental Treatment of Transfusion Dependent 5q Minus Syndrome With Leucovorin
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 1998
- Completion date
- July 31, 2002
- Enrollment
- 14
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
5q minus syndrome, myelodysplastic syndrome